tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

GB:0RUG Stock Latest News

bioMerieux price target lowered to EUR 100 from EUR 110 at Barclays
The FlybioMerieux price target lowered to EUR 100 from EUR 110 at Barclays
7d ago
bioMerieux price target lowered to EUR 109 from EUR 112 at Morgan Stanley
PremiumThe Fly
bioMerieux price target lowered to EUR 109 from EUR 112 at Morgan Stanley
29d ago
bioMerieux downgraded to Neutral from Outperform at BNP Paribas
PremiumThe Fly
bioMerieux downgraded to Neutral from Outperform at BNP Paribas
1M ago
bioMerieux price target lowered to EUR 112 from EUR 113 at Morgan Stanley
PremiumThe Fly
bioMerieux price target lowered to EUR 112 from EUR 113 at Morgan Stanley
3M ago
bioMerieux upgraded to Neutral from Underperform at BofA
PremiumThe Fly
bioMerieux upgraded to Neutral from Underperform at BofA
3M ago
bioMerieux (0RUG) Announces Q2 Dividend: Read On for Important Dates
PremiumDividendsbioMerieux (0RUG) Announces Q2 Dividend: Read On for Important Dates
12M ago
bioMérieux’s VITEK® COMPACT PRO Gains FDA Approval to Combat Antibiotic Resistance
Premium
Company Announcements
bioMérieux’s VITEK® COMPACT PRO Gains FDA Approval to Combat Antibiotic Resistance
12M ago
bioMérieux Prepares for May 2025 Shareholder Meeting
Premium
Company Announcements
bioMérieux Prepares for May 2025 Shareholder Meeting
12M ago
bioMérieux Launches Innovative Diagnostic Solution for Food Safety
PremiumCompany Announcements
bioMérieux Launches Innovative Diagnostic Solution for Food Safety
1y ago
bioMérieux Gains FDA Clearance for New Gastrointestinal Panel
PremiumCompany Announcements
bioMérieux Gains FDA Clearance for New Gastrointestinal Panel
1y ago
bioMérieux to Present Strategic Growth Plans at J.P. Morgan Healthcare Conference
PremiumCompany Announcements
bioMérieux to Present Strategic Growth Plans at J.P. Morgan Healthcare Conference
1y ago
bioMérieux Gains FDA Clearance for Tropical Fever Test
PremiumCompany Announcements
bioMérieux Gains FDA Clearance for Tropical Fever Test
1y ago
bioMérieux’s Strong Growth Continues in 2024
PremiumCompany AnnouncementsbioMérieux’s Strong Growth Continues in 2024
1y ago
bioMerieux Launches New Vitamin B12 Test
Premium
Company Announcements
bioMerieux Launches New Vitamin B12 Test
1y ago
bioMérieux Reports Voting Rights and Shares
Premium
Company Announcements
bioMérieux Reports Voting Rights and Shares
1y ago
bioMerieux Reports Strong H1 2024 Growth
PremiumCompany Announcements
bioMerieux Reports Strong H1 2024 Growth
1y ago
bioMerieux Announces Latest Voting Rights Totals
PremiumCompany Announcements
bioMerieux Announces Latest Voting Rights Totals
2y ago
bioMerieux Advances Rapid Diagnostic Testing
PremiumCompany Announcements
bioMerieux Advances Rapid Diagnostic Testing
2y ago
bioMérieux’s VITEK System Wins FDA Clearance
PremiumCompany Announcements
bioMérieux’s VITEK System Wins FDA Clearance
2y ago
bioMerieux Reports Voting Rights and Shares
PremiumCompany AnnouncementsbioMerieux Reports Voting Rights and Shares
2y ago
bioMerieux’s New Test to Revolutionize Brain Injury Assessment
Premium
Company Announcements
bioMerieux’s New Test to Revolutionize Brain Injury Assessment
2y ago
bioMerieux (0RUG) Declares Q2 Dividend: Important Details for Shareholders
Premium
Dividends
bioMerieux (0RUG) Declares Q2 Dividend: Important Details for Shareholders
2y ago

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >